Skip to content
Riskpilot
← Back to search
Sign in
Get full access
S&R Hemoptic AB
AB
Active
Org 5591236210
Månskensvägen 179, 146 46
Tullinge
Construction of residential and non-residential buildings
· NACE 4100
Est. 2017
1-4 employees
Watchlist
Share
Sweden
/
Companies
/
Construction of residential and non-residential buildings
/
S&R Hemoptic AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
2M
3M
5M
0M
2020
0M
2021
0M
2022
4M
2023
3M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
405
302
3 657
3 452
Staff expenses
—
—
−0
−1 525
−1 925
EBITDA
−1
9
50
345
100
Depreciation & amort.
−0
−0
—
—
—
EBIT
−1
9
50
345
100
Net financials
—
—
−0
−11
−13
Profit before tax
−1
9
50
241
180
Tax
−0
−8
−12
−58
−66
Net profit
−1
1
38
183
114
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
50
143
169
915
488
Equity
43
45
83
265
380
Long-term debt
0
0
—
—
—
Short-term debt
6
98
86
557
109
Total debt
6
98
86
557
109
Financial ratios
5-year trend
EBITDA margin
2.9%
This company
15.8%
Market median
-82% vs market
2020
2024
Equity ratio
77.8%
This company
38.2%
Market median
+104% vs market
2020
2024
Return on equity
30.1%
This company
18.4%
Market median
+64% vs market
2020
2024
Net profit margin
3.3%
This company
8.1%
Market median
-59% vs market
2020
2024
Asset turnover
7.07×
This company
1.12×
Market median
+531% vs market
2020
2024
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on S&R Hemoptic AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network